Correlation Between Symrise Ag and Novozymes A/S
Can any of the company-specific risk be diversified away by investing in both Symrise Ag and Novozymes A/S at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Symrise Ag and Novozymes A/S into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Symrise Ag PK and Novozymes AS B, you can compare the effects of market volatilities on Symrise Ag and Novozymes A/S and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Symrise Ag with a short position of Novozymes A/S. Check out your portfolio center. Please also check ongoing floating volatility patterns of Symrise Ag and Novozymes A/S.
Diversification Opportunities for Symrise Ag and Novozymes A/S
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Symrise and Novozymes is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Symrise Ag PK and Novozymes AS B in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novozymes AS B and Symrise Ag is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Symrise Ag PK are associated (or correlated) with Novozymes A/S. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novozymes AS B has no effect on the direction of Symrise Ag i.e., Symrise Ag and Novozymes A/S go up and down completely randomly.
Pair Corralation between Symrise Ag and Novozymes A/S
Assuming the 90 days horizon Symrise Ag PK is expected to under-perform the Novozymes A/S. But the pink sheet apears to be less risky and, when comparing its historical volatility, Symrise Ag PK is 1.89 times less risky than Novozymes A/S. The pink sheet trades about -0.1 of its potential returns per unit of risk. The Novozymes AS B is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 5,714 in Novozymes AS B on December 2, 2024 and sell it today you would earn a total of 351.00 from holding Novozymes AS B or generate 6.14% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Symrise Ag PK vs. Novozymes AS B
Performance |
Timeline |
Symrise Ag PK |
Novozymes AS B |
Symrise Ag and Novozymes A/S Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Symrise Ag and Novozymes A/S
The main advantage of trading using opposite Symrise Ag and Novozymes A/S positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Symrise Ag position performs unexpectedly, Novozymes A/S can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novozymes A/S will offset losses from the drop in Novozymes A/S's long position.Symrise Ag vs. Givaudan SA ADR | Symrise Ag vs. Sysmex Corp | Symrise Ag vs. Shin Etsu Chemical Co | Symrise Ag vs. Brenntag AG ADR |
Novozymes A/S vs. Symrise Ag PK | Novozymes A/S vs. Givaudan SA | Novozymes A/S vs. Sika AG | Novozymes A/S vs. Sika AG ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |